Increased workload fully activates the blunted IRS-1/PI3-kinase/Akt signaling pathway in atrophied uremic muscle  Y. Chen, S. Sood, J. Biada, R. Roth,

Slides:



Advertisements
Similar presentations
Volume 76, Issue 7, Pages (October 2009)
Advertisements

Volume 70, Issue 3, Pages (August 2006)
Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells  W. Qi, X. Chen, S. Twigg, T.S. Polhill,
Cardiac remodeling and dysfunction in nephrotic syndrome
Volume 73, Issue 3, Pages (February 2008)
Volume 69, Issue 4, Pages (February 2006)
H.T. Lee, M. Kim, M. Jan, R.B. Penn, C.W. Emala  Kidney International 
Volume 69, Issue 8, Pages (April 2006)
IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy  J.-A. Moon,
Volume 72, Issue 1, Pages (July 2007)
M.H.A. Baccora, P. Cortes, C. Hassett, D.W. Taube, J. Yee 
Volume 73, Issue 4, Pages (February 2008)
Modulation of melanocortin signaling ameliorates uremic cachexia
Volume 58, Issue 1, Pages (July 2000)
Kisspeptin stimulates progesterone secretion via the Erk1/2 mitogen-activated protein kinase signaling pathway in rat luteal cells  Jing Peng, M.D., Min.
Volume 78, Issue 2, Pages (July 2010)
Volume 79, Issue 7, Pages (April 2011)
Volume 71, Issue 8, Pages (April 2007)
Volume 71, Issue 9, Pages (May 2007)
Intestinal phosphate absorption in a model of chronic renal failure
Volume 69, Issue 6, Pages (March 2006)
Activation of Erk1/2 and Akt following unilateral ureteral obstruction
Proinflammatory effects of iron sucrose in chronic kidney disease
Volume 69, Issue 2, Pages (January 2006)
1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression  Yingjian Li, Bradley C.
Volume 70, Issue 11, Pages (December 2006)
Volume 78, Issue 6, Pages (September 2010)
Volume 73, Issue 7, Pages (April 2008)
Wei-Zhong Ying, Paul W. Sanders  Kidney International 
Volume 66, Issue 2, Pages (August 2004)
Mitogen-activated protein kinase upregulation reduces renal D1 receptor affinity and G- protein coupling in obese rats  A.A. Banday, F.R. Fazili, A. Marwaha,
COX-2 inhibition attenuates endotoxin-induced downregulation of organic anion transporters in the rat renal cortex  Klaus Höcherl, Christoph Schmidt,
Volume 74, Issue 9, Pages (November 2008)
Blood pressure targets in hemodialysis patients
Volume 76, Issue 7, Pages (October 2009)
Volume 73, Issue 6, Pages (March 2008)
The third World Kidney Day: Looking back and thinking forward
Volume 72, Issue 8, Pages (October 2007)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 69, Issue 10, Pages (May 2006)
M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, M.-J. Tang 
Volume 73, Issue 3, Pages (February 2008)
Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy
Kaihui Liang, Nosratola D. Vaziri  Kidney International 
Chien-Te Lee, Viet M. Huynh, Li-Wen Lai, Yeong-Hau H. Lien 
What can be learned using microarrays?
Volume 56, Issue 5, Pages (November 1999)
Volume 70, Issue 5, Pages (September 2006)
TGF-β type II receptor deficiency prevents renal injury via decrease in ERK activity in crescentic glomerulonephritis  C.Y. Song, B.C. Kim, H.K. Hong,
Endothelin antagonists in renal disease
Organ transplantation goes to the movies
Volume 72, Issue 3, Pages (August 2007)
Direct effects of dexamethasone on human podocytes
Volume 70, Issue 2, Pages (July 2006)
Volume 73, Issue 8, Pages (April 2008)
Is it the low-protein diet or simply the salt restriction?
Volume 69, Issue 2, Pages (January 2006)
Urinalysis in Western culture: A brief history
Volume 70, Issue 3, Pages (August 2006)
Volume 70, Issue 3, Pages (August 2006)
Volume 71, Issue 9, Pages (May 2007)
Volume 64, Issue 1, Pages (July 2003)
Volume 70, Issue 5, Pages (September 2006)
Increased renal calcium and magnesium transporter abundance in streptozotocin- induced diabetes mellitus  C-T. Lee, Y-H.H. Lien, L-W. Lai, J-B. Chen, C-R.
Volume 72, Issue 11, Pages (December 2007)
Cardiac resistance to growth hormone in uremia
The International Pediatric Peritonitis Registry: Starting to walk
Volume 75, Issue 8, Pages (April 2009)
Volume 61, Issue 4, Pages (April 2002)
Presentation transcript:

Increased workload fully activates the blunted IRS-1/PI3-kinase/Akt signaling pathway in atrophied uremic muscle  Y. Chen, S. Sood, J. Biada, R. Roth, R. Rabkin  Kidney International  Volume 73, Issue 7, Pages 848-855 (April 2008) DOI: 10.1038/sj.ki.5002801 Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 1 WO increased plantaris muscle IGF-1, MGF, and SOCS3 mRNA levels in CRF and SN rats and depressed elevated SOCS2 mRNA levels in CRF. Plantaris muscles from both limbs were collected after 7 days of unilateral WO. mRNA levels were measured by real-time PCR and corrected for the internal housekeeping gene 18S. Results are mean±s.e.m. from eight muscles per group, were expressed relative to the values obtained from the nonloaded control plantaris muscle of the SN group, and assigned a mean value of 100. *P<0.05, CRF vs SN; #P<0.05 and ##P<0.01 WO vs control. Kidney International 2008 73, 848-855DOI: (10.1038/sj.ki.5002801) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 2 Signaling protein levels in nonloaded control plantaris muscle of SN and CRF rats were not significantly different. (a) Protein values were expressed as a percentage of SN control mean (n=6 per group). (b) Western immunoblots of selected proteins of pooled samples from all animals in each group run in duplicate. Kidney International 2008 73, 848-855DOI: (10.1038/sj.ki.5002801) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 3 Signaling protein levels in nonloaded control and work-overloaded plantaris muscle of SN rats. Work overload (WO) induced a significant increase in several signaling proteins. (a) Mean and s.e.m. of individual protein values were expressed as a percentage of the SN control plantaris muscle mean. #P<0.05 and ##P<0.01 WO vs control. (b) Western immunoblots of proteins in pooled samples of all control or WO muscles from SN and CRF rats run in duplicate. Kidney International 2008 73, 848-855DOI: (10.1038/sj.ki.5002801) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 4 Basal levels of phosphorylated signaling proteins in control nonloaded plantaris muscle of SN and CRF rats. (a) phospho-IRS-1 and phospho-Akt levels were significantly reduced in CRF rats. Mean and s.e.m. of individual phosphoprotein levels were expressed as a percentage of the average SN control value. (b) Relative phosphoprotein levels. Phosphoprotein levels corrected for specific protein levels were expressed as a percentage of mean SN value. *P<0.05 CRF vs SN. (c) Western immunoblots of selected phosphoproteins in pooled samples from all animals in each group run in duplicate. Kidney International 2008 73, 848-855DOI: (10.1038/sj.ki.5002801) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 5 Phosphorylated signaling protein levels in control nonloaded and WO plantaris muscle of SN and CRF rats. (a) Phosphoprotein levels in control and WO plantaris muscles of SN group. Mean and s.e.m. of individual values were expressed as a percentage of the SN control plantaris muscle mean. (b) Relative phosphoprotein levels. #P<0.05 and ##P<0.01 WO vs control. (c) Western immunoblots of selected phosphoproteins in pooled samples of all plantaris muscles in each group run in duplicate. Kidney International 2008 73, 848-855DOI: (10.1038/sj.ki.5002801) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 6 Western immunoblot of the 14-kDa actin fragment in control and work-overloaded plantaris muscle of CRF and SN rats. Fragment levels increased in CRF then decreased following an increase in workload. Samples consisted of duplicate pooled extracts from each group. Kidney International 2008 73, 848-855DOI: (10.1038/sj.ki.5002801) Copyright © 2008 International Society of Nephrology Terms and Conditions